2021
DOI: 10.1016/j.rceng.2019.10.013
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic value of multimodal assessment of congestion in acute heart failure

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

0
4
0
1

Year Published

2021
2021
2024
2024

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(5 citation statements)
references
References 44 publications
0
4
0
1
Order By: Relevance
“…In contrast, Marini C et al did not show that pharmacological treatment of AHF under pulmonary ultrasound guidance had an impact on patient mortality at 90-day follow-up [35]. Also, other investigators did not confirm that the severity of lung ultrasound lesions influenced the prognosis of patients hospitalized for cardiovascular decompensation, while NTproBNP levels proved to be an independent prognostic factor [36]. According to other authors, both elevated NTproBNP levels and B-line counts ≥15 were associated with the risk of death and hospitalization for heart failure [37].…”
Section: Discussionmentioning
confidence: 93%
“…In contrast, Marini C et al did not show that pharmacological treatment of AHF under pulmonary ultrasound guidance had an impact on patient mortality at 90-day follow-up [35]. Also, other investigators did not confirm that the severity of lung ultrasound lesions influenced the prognosis of patients hospitalized for cardiovascular decompensation, while NTproBNP levels proved to be an independent prognostic factor [36]. According to other authors, both elevated NTproBNP levels and B-line counts ≥15 were associated with the risk of death and hospitalization for heart failure [37].…”
Section: Discussionmentioning
confidence: 93%
“…En un paciente con IC crónica la presencia de signos clínicos de congestión traduce un estado de sobrecarga de volumen, y se correlaciona con mayor gravedad del cuadro y peor pronóstico 7 , especialmente si estos no responden de forma adecuada a la intensificación del tratamiento. En la actualidad se disponen de diferentes herramientas que pue-den ayudar en el reto clínico que supone la identificación del estado congestivo en pacientes con IC 8 , lo que incluye, entre otras, las técnicas de imagen y los biomarcadores; aun así, cabe resaltar el valor diagnóstico y pronóstico que continúa teniendo una detallada exploración física en la consulta 7 . Las descompensaciones congestivas constituyen el motivo más frecuente de hospitalización por agudización en los pacientes con IC; la necesidad de ingreso por este motivo se correlaciona con un incremento de la mortalidad, que es más marcado durante el periodo inmediato tras una hospitalización reciente 9 y en caso de hospitalizaciones recurrentes 10 .…”
Section: Discussionunclassified
“…The LUS showed higher sensitivity ratio 1.2 (95% CI, 1.08-1.34; p < 0.001) compared with CxR [62,63,71], computerized tomography (CT) , and echocardiogram [74] in the diagnosis of HF, and using LUS with the clinical evaluation reduced diagnostic errors as compared to [CxR+Nt-proBNP] combination [64]. However, mortality was associated to significantly lower IVC collapse [65,70,71], and a greater number of lung B-lines; and higher NT-proBNP levels [65,[68][69][70] without differences in the BIA parameters. Among the most individuals with ambulatory follow-up and preserved ejection fraction [66,73], the submaximal exercise increases B-lines number to level of higher probability of 12-month all-cause death or/ and higher probability of HF decompensation [45,[50][51][52]56,61].…”
Section: Risk Of Readmission and Mortality With 3month Follow-upmentioning
confidence: 99%